The application of nutrition support in conservative treatment of chylous ascites after abdominal surgery
Autor: | Da-Li Wang, Wenduo Zhang, Shu-Rui Ouyang, Shen-Yang Cai, Hai-Long Luo, Wu Pan, Zai-Rong Wei |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2016 |
Předmět: |
medicine.medical_specialty
Therapeutics and Clinical Risk Management somatostatin 030204 cardiovascular system & hematology 03 medical and health sciences Peritoneal cavity 0302 clinical medicine Chylous ascites chylous ascites medicine enteral nutrition Pharmacology (medical) General Pharmacology Toxicology and Pharmaceutics Original Research Chemical Health and Safety business.industry General Medicine Surgery Conservative treatment Parenteral nutrition medicine.anatomical_structure Lymphatic system 030220 oncology & carcinogenesis medium-chain triglycerides Nutrition support total parenteral nutrition Complication business Safety Research Abdominal surgery |
Zdroj: | Therapeutics and Clinical Risk Management |
ISSN: | 1178-203X |
Popis: | Wu Pan,1 Shen-Yang Cai,2 Hai-Long Luo,2 Shu-Rui Ouyang,1 Wen-Duo Zhang,1 Zai-Rong Wei,1 Da-Li Wang1 1Department of Plastic & Vascular Surgery, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou, 2Department of Hepatopancreatobiliary Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China Background: Chylous ascites is the pathologic leakage of triglycerides-rich lymphatic fluid into the peritoneal cavity. Chylous ascites is a rare complication in abdominal surgery. This study aimed to find a relatively better method for nutrition support in the treatment of chylous ascites after abdominal surgery. Methods: This study was a retrospective study. This study retrospectively reviewed patients who underwent abdominal surgery and developed chylous ascites, from the year 2010 to 2014, at the West China Hospital of Sichuan University and the Affiliated Hospital of Zunyi Medical College. Fifty-eight patients who developed chylous ascites after abdominal surgery were included in the study. The clinical effect of somatostatin was evaluated. The differences in the curative efficacy among a daily diet, a low-fat diet supplemented with medium-chain triglyceride (MCT), and total parenteral nutrition (TPN) were also analyzed in this study. Results: Complete clinical success was reached earlier in patients treated with somatostatin (P |
Databáze: | OpenAIRE |
Externí odkaz: |